ProfileGDS5678 / 1424530_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 46% 46% 46% 46% 49% 44% 44% 44% 46% 48% 46% 50% 57% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1287846
GSM967853U87-EV human glioblastoma xenograft - Control 23.0779646
GSM967854U87-EV human glioblastoma xenograft - Control 33.0868346
GSM967855U87-EV human glioblastoma xenograft - Control 43.0150546
GSM967856U87-EV human glioblastoma xenograft - Control 53.1152949
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1064644
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0799844
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0109344
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0629546
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1096648
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0682146
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1530150
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4479857
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0671646